Search Results 1281-1290 of 19416 for Hemoglobin

  1. A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma - Mayo Clinic

    Subject has absolute neutrophil count < 1000/μL, platelet count < 75,000/μL, and hemoglobin < 8 g/dL (< 5 mmol/L) at Screening; Subject has total serum ...

  2. Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction - Mayo Clinic

    Hemoglobin < 8.0 g/dl; Glomerular filtration rate < 20 ml/min/1.73 m2 on most recent clinical laboratories; SBP < 110 mmHg or > 180 mmHg at consent; Diastolic ...

  3. Hip Replacement Clinical Trials - Mayo Clinic Research

    We will collect both non-invasive hemoglobin and conventional serum hemoglobin labs from patients postoperatively following outpatient total joint ...

  4. Study Of Chemotherapy Plus Ipatasertib For People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial - Mayo Clinic

    ... hemoglobin (Hb)A1c, suggesting poorly controlled diabetes - Participants who are on a stable dose of oral diabetes medication >= 2 weeks prior to initiation ...

  5. A Study of Levosimendan in Pulmonary Hypertension (PH) with Heart Failure (HF) and Preserved Left Ventricular Ejection Fraction (pEF) Patients - Mayo Clinic

    Hemoglobin < 80 g/L. Serum potassium < 3.0 mmol/L or > 5.5 mmol/L at baseline that is unresponsive to management . Participating Mayo Clinic locations. Study ...

  6. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Hemoglobin ≥ 7.0 g/dL (without transfusion or growth factor support within 14 days prior to registration). Absolute neutrophil count (ANC) ≥ 1,000 cells ...

  7. Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer - Mayo Clinic

    Hemoglobin ≥10 g/dL. WBC ≥4000/μL. ANC ≥2000/μL. Platelet count ≥100,000/μL. INR within institutional normal limits. aPTT within institutional normal ...

  8. Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD - Mayo Clinic

    Hemoglobin <11 g/dL. Signs of hemolysis with abnormal values by any of the following hemolytic markers: Increased absolute reticulocyte counts (above ULN); ...

  9. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1000/mm^3;; Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase ...

  10. Heartburn medicines and B-12 deficiency - Mayo Clinic

    Medicines to treat heartburn, also called gastroesophageal reflux disease (GERD), work by blocking stomach acid. Blocking stomach acid can keep the body from ...